Brooktree Capital Management Merck & Co., Inc. Transaction History

Brooktree Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $249,786 - $279,995	-3,398 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $3,469 - $4,345	-48 Reduced 1.39%	3,398 $260,000
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $71 - $78	-1 Reduced 0.03%	3,446 $259,000
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $174,078 - $205,046	-2,528 Reduced 42.31%	3,447 $266,000
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $16,578 - $18,399	-231 Reduced 3.72%	5,975 $488,000
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $38,016 - $52,691	600 Added 10.7%	6,206 $477,000
Q4 2019 Feb 26, 2020	BUY	$77.58 - $87.54 $434,913 - $490,749	5,606 New	5,606 $510,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brooktree Capital Management with notifications on news.